insulin Aspart injection

BIOLOGICAL2 trials

Sponsors

Tonghua Dongbao Pharmaceutical Co.,Ltd, Beijing Hospital

Conditions

DiabetesType 2 Diabetes Mellitus

Phase 3

A Phase III Study of Insulin Aspart Injection to Evaluate the Efficacy and Safety

CompletedNCT02491528

Tonghua Dongbao Pharmaceutical Co.,LtdDiabetes

Start: 2015-06-19End: 2016-08-12Updated: 2023-12-22

Unknown Phase

Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T2DM

CompletedNCT05417841

Beijing HospitalType 2 Diabetes Mellitus

Start: 2023-03-23End: 2025-08-15Updated: 2025-12-03